The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review

SUMMARY: For patients presenting with clinically isolated syndrome, the treating clinician needs to advise the patient on the probability of conversion to clinically definite multiple sclerosis. MR imaging may give useful prognostic information, and there is large body of literature pertaining to the use of MR imaging in assessing patients presenting with clinically isolated syndrome. This literature review evaluates the accuracy of MR imaging in predicting which patients with clinically isolated syndrome will go on to develop long-term disease and/or disability. New and emerging MR imaging technologies and their applicability to patients with clinically isolated syndrome are also considered.

[1]  Michael Wall,et al.  Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial , 2002, Multiple sclerosis.

[2]  J A Helpern,et al.  Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.

[3]  J. Ranjeva,et al.  Efficiency of cognitive control recruitment in the very early stage of multiple sclerosis: a one-year fMRI follow-up study , 2008, Multiple sclerosis.

[4]  A. Dale,et al.  Improved Localizadon of Cortical Activity by Combining EEG and MEG with MRI Cortical Surface Reconstruction: A Linear Approach , 1993, Journal of Cognitive Neuroscience.

[5]  A J Thompson,et al.  Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.

[6]  Wei-yan Zhang,et al.  Prognostic value of magnetic resonance imaging in patients with clinically isolated syndrome conversion to multiple sclerosis: a meta-analysis. , 2013, Neurology India.

[7]  R. Kinkel,et al.  Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. , 2012, Archives of neurology.

[8]  M. Filippi,et al.  Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes , 2005, The Lancet Neurology.

[9]  C. Enzinger,et al.  Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome , 2011, Multiple sclerosis.

[10]  A. Thompson,et al.  Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI , 2001, Journal of neurology, neurosurgery, and psychiatry.

[11]  F. Barkhof,et al.  MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome , 2009, BMC neurology.

[12]  Jeffrey A. Cohen,et al.  Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo groupy , 2002, Multiple sclerosis.

[13]  M. Ron,et al.  Cognitive impairment in multiple sclerosis can be predicted by imaging early in the disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[14]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[15]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[16]  I. Moseley,et al.  Multisequence MRI in clinically isolated syndromes and the early development of MS , 1999, Neurology.

[17]  Hans Lassmann,et al.  The relation between inflammation and neurodegeneration in multiple sclerosis brains , 2009, Brain : a journal of neurology.

[18]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[19]  Michael Wall,et al.  MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group , 2002, Neurology.

[20]  G. Comi,et al.  A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS , 2008, Journal of Neurology.

[21]  Donald H. Lee,et al.  Increased deep gray matter iron is present in clinically isolated syndromes. , 2014, Multiple sclerosis and related disorders.

[22]  Marco Rovaris,et al.  A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. , 2009, Archives of neurology.

[23]  R. Alroughani,et al.  Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria , 2012, ISRN neurology.

[24]  R. Henry,et al.  Regional grey matter atrophy in clinically isolated syndromes at presentation , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[25]  S Ropele,et al.  Determinants of brain iron in multiple sclerosis , 2011, Neurology.

[26]  Rohit Bakshi,et al.  Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2010, Multiple sclerosis.

[27]  G. Barker,et al.  Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS , 2002, Neurology.

[28]  H. McFarland,et al.  Outcomes assessment in multiple sclerosis clinical trials: a critical analysis , 1995, Multiple sclerosis.

[29]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[30]  M. Calabrese,et al.  The predictive value of gray matter atrophy in clinically isolated syndromes , 2011, Neurology.

[31]  Jeffrey A. Cohen,et al.  Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.

[32]  M. Dwyer,et al.  Thalamic atrophy is associated with development of clinically definite multiple sclerosis. , 2013, Radiology.

[33]  M. Dwyer,et al.  Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy , 2012, American Journal of Neuroradiology.

[34]  S Ropele,et al.  Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis , 2011, Multiple sclerosis.

[35]  G. Comi,et al.  Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. , 2000, AJNR. American journal of neuroradiology.

[36]  A. Thompson,et al.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.

[37]  C. Beaulieu,et al.  Determinants of anisotropic water diffusion in nerves , 1994, Magnetic resonance in medicine.

[38]  M. Battaglini,et al.  Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.

[39]  Maria Assunta Rocca,et al.  A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2005, NeuroImage.

[40]  C. Pozzilli,et al.  The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis , 2004, Journal of Neurology.

[41]  Ludwig Kappos,et al.  Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results. , 2007, Archives of neurology.

[42]  Margit Jehna,et al.  Quantitative susceptibility mapping in multiple sclerosis. , 2013, Radiology.

[43]  M. Filippi,et al.  Simple and complex movement‐associated functional MRI changes in patients at presentation with clinically isolated syndromes suggestive of multiple sclerosis , 2004, Human brain mapping.

[44]  Dana Horakova,et al.  Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study , 2012, PloS one.

[45]  H. Schild,et al.  Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy , 2007, American Journal of Neuroradiology.

[46]  F. Barkhof,et al.  A three-year, multi-parametric MRI study in patients at presentation with CIS , 2008, Journal of Neurology.

[47]  M. Filippi,et al.  A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis. , 2005, AJNR. American journal of neuroradiology.

[48]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[49]  R. Kinkel,et al.  Bimonthly cranial MRI activity following an isolated monosymptomatic demyelinating syndrome: potential outcome measures for future multiple sclerosis `prevention' trials , 1999, Multiple sclerosis.

[50]  Minna Raunio,et al.  Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: Prospective clinical and MRI follow-up study , 2011, Journal of Neuroimmunology.

[51]  C. Polman,et al.  Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. , 2004, Archives of neurology.

[52]  M. Dwyer,et al.  Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis , 2012, American Journal of Neuroradiology.

[53]  J. Ranjeva,et al.  Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis - a two-year longitudinal MRI/MRSI study of corpus callosum , 2007, Multiple sclerosis.

[54]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[55]  Chunshui Yu,et al.  Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI , 2012, Acta radiologica.

[56]  F. Barkhof,et al.  Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b , 2008, Journal of Neurology.

[57]  E. Cristiano,et al.  Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes , 2013, Multiple sclerosis.

[58]  H P Hartung,et al.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.

[59]  F. Bouwman,et al.  Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis , 2009, Neurology.

[60]  M. Filippi,et al.  Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis , 2011, Multiple sclerosis.

[61]  Massimo Filippi,et al.  Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. , 2010, Radiology.

[62]  David H. Miller,et al.  Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2002, Annals of neurology.

[63]  H. Schild,et al.  Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis , 2008, Neuroradiology.

[64]  G. Barker,et al.  Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis , 1999, Journal of the Neurological Sciences.

[65]  Carlo Pozzilli,et al.  A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. , 2002, Magnetic resonance imaging.

[66]  M. Battaglini,et al.  Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis , 2011, Multiple sclerosis.

[67]  Christian Confavreux,et al.  Clinical outcomes assessment in multiple sclerosis , 1996, Annals of neurology.

[68]  Nick C Fox,et al.  Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[69]  R. Hernández-Clares,et al.  Plasma exchange for steroid-refractory relapses in multiple sclerosis: an observational, MRI pilot study. , 2013, Clinical therapeutics.

[70]  Nicola De Stefano,et al.  Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS , 2009, Journal of the Neurological Sciences.

[71]  Massimo Filippi,et al.  A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes , 2008, NeuroImage.

[72]  Yunyun Duan,et al.  Brain plasticity in relapsing–remitting multiple sclerosis: Evidence from resting-state fMRI , 2011, Journal of the Neurological Sciences.

[73]  Gian Domenico Iannetti,et al.  Cortical motor reorganization after a single clinical attack of multiple sclerosis. , 2002, Brain : a journal of neurology.

[74]  Robert Zivadinov,et al.  Quantitative diffusion weighted imaging measures in patients with multiple sclerosis , 2007, NeuroImage.

[75]  À. Rovira,et al.  Brainstem lesions in clinically isolated syndromes , 2010, Neurology.

[76]  Marco Bozzali,et al.  Gray- and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. , 2010, Radiology.

[77]  Hompson,et al.  A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .

[78]  D. Louis Collins,et al.  Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis , 2010, NeuroImage.

[79]  Marco Bozzali,et al.  Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. , 2010, Radiology.

[80]  M. Filippo,et al.  Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[81]  Ludwig Kappos,et al.  Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. , 2009, Archives of neurology.

[82]  B. Thrower Clinically isolated syndromes , 2007, Neurology.

[83]  Derek K Jones,et al.  Investigating exchange and multicomponent relaxation in fully‐balanced steady‐state free precession imaging , 2008, Journal of magnetic resonance imaging : JMRI.

[84]  S Ropele,et al.  Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.

[85]  G J Barker,et al.  Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. , 2005, Brain : a journal of neurology.

[86]  À. Rovira,et al.  Baseline MRI predicts future attacks and disability in clinically isolated syndromes , 2006, Neurology.

[87]  P. Pasqualetti,et al.  Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome , 2005, Multiple sclerosis.

[88]  M. Rovaris,et al.  A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2007, Journal of Neurology.

[89]  P. Matthews,et al.  Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability , 2011, Multiple sclerosis.

[90]  J. De Keyser,et al.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.

[91]  M. Battaglini,et al.  Evaluating and reducing the impact of white matter lesions on brain volume measurements , 2012, Human brain mapping.

[92]  G. Johnson,et al.  White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis , 2009, Journal of the Neurological Sciences.

[93]  M. Filippi,et al.  Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. , 2011, Radiology.

[94]  Yunyun Duan,et al.  Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. , 2008, European journal of radiology.

[95]  A. Janssens,et al.  Callosal lesion predicts future attacks after clinically isolated syndrome , 2009, Neurology.

[96]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[97]  A J Thompson,et al.  Texture analysis of magnetization transfer maps from patients with clinically isolated syndrome and multiple sclerosis , 2009, Journal of magnetic resonance imaging : JMRI.

[98]  Brian K. Rutt,et al.  Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI , 2012, NeuroImage.

[99]  G. B. Pike,et al.  Pulsed magnetization transfer contrast in gradient echo imaging: A two‐pool analytic description of signal response , 1996, Magnetic resonance in medicine.